The use of the antioxidant trimetazidine (Preductal) in the combined therapy of acute myocardial infarct
1996
: 86 patients with acute transmural and macrofocal myocardial infarction received combined treatment which included standard therapy (thrombolytic drugs, beta-blockers, APP inhibitors, nitrates, aspirin) and antioxidant trimetasidine. The addition of the latter was beneficial: the size of the myocardial lesion was limited, electrical instability of the heart attenuated, early dilatation of the left heart prevented.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI